Abstracts
Print PageAIDS Vaccine received a total of 426 regular and 78 late breaker abstracts in the following topics:
Adjuvants, Immunogens and Inserts
Animal Models and Preclinical Trials
B Cell Immunology and Antibody Functions
Clinical Vaccine Trials and Trial Site Challenges
HIV Transmission and Viral Diversity
Immunogenetic Factors
Innate Immunity
Mucosal Immunity
Non-vaccine Prevention
Pediatric and Adolescent Infections and Trials
Social/Ethical/Access/Regulatory Issues
T Cell Immunity
Vaccine Concepts and Design
New scientific sessions presented at AIDS Vaccine 2012 included:
Plenary 01: HIV Vaccines in the Broader HIV Preventiosn Landscape
Oral Abstract 06: V1/V2 Antibody Responses
Symposium 04: Cross-Cutting Issues in Clinical Trial Design
Symposium 08: Therapeutic Vaccination and Strategies for the Cure